{
  "ptid_time": "024_S_5290_2019-09-09",
  "img_path": "/data/qiuhui/data/adni/images/024_S_5290/2019-09-09/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 16,560 mm³, 41.0% below the reference mean. With a Z-score of -0.94 (17.4th percentile), this represents normal volume ; hippocampal volume measures 7,492 mm³, 5.3% above the reference mean. With a Z-score of 0.49 (68.7th percentile), this represents normal volume ; whole brain volume measures 982,588 mm³, 0.8% above the reference mean. With a Z-score of 0.10 (54.1th percentile), this represents normal volume ; entorhinal cortex volume measures 4,541 mm³, 23.6% above the reference mean. With a Z-score of 1.45 (92.7th percentile), this represents mild enlargement; fusiform gyrus volume measures 19,525 mm³, 14.8% above the reference mean. With a Z-score of 1.34 (91.0th percentile), this represents mild enlargement; middle temporal gyrus volume measures 19,145 mm³, 0.1% below the reference mean. With a Z-score of -0.01 (49.6th percentile), this represents normal volume . ",
  "text_data": "Age is 73.0 years. Gender is Female. Education: 12 years. MMSE: 30.0. MoCA: 30.0. Logical Memory: 17.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.80 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain volume measurements are largely within normal ranges or even mildly enlarged, with no significant atrophy in key regions like the hippocampus or middle temporal gyrus. Cognitive scores (MMSE and MoCA) are perfect (30/30), suggesting no current cognitive impairment. However, the presence of APOE4 (one allele) and profound AV45 (amyloid) elevation indicates high amyloid burden, a risk factor for future cognitive decline.  \n\n**Diagnosis:** **CN (Cognitively Normal)**  \n**Confidence:** **Medium** (due to conflicting biomarkers—normal structure/function but high amyloid burden, which may precede symptoms)",
  "timestamp": "2025-07-26T03:23:55.119232"
}